Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
NYU's Ambulatory Care Center at 240 East 38th Street, New York
will be on Wednesday, March 9, at 6:30-8:00 PM, on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Avenues.
We are excited to have have guest speaker Dr. Jennifer Wolkin attend this meeting, who will discuss mindfulness and meditation in relation to vitiligo. Our resident experts, Dr. Nada Elbuluk and Dr. Beth McLellan will be present and answer questions. There will also be a brief presentation on research updates in vitiligo.
Please let us know if you will be able to attend by email email@example.com.
We look forward to seeing everyone there!
Like us on Facebook for updates and interesting articles at: facebook.com/nyvitiligo
- What's better: laser or phototherapy?
In a recent study researchers assessed effect and safety of different laser and phototherapy treatments, such as excimer laser/light, narrowband UVB, UVA and PUVA. No significa...
- How can I cure vitiligo?
There is no cure for vitiligo, but there are a number of effective treatment options that can be discussed with your GP or dermatologist. The aim of treatment is to stop new pat...
- Can Ayurveda help with vitiligo?
People have used herbs and natural remedies to treat skin conditions for centuries. Vitiligo is an auto-immune condition that causes white patches of skin to develop and expand...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.